CompletedNCT01646112
Uncertain Genetic Test Results for Lynch Syndrome
Studying Hereditary nonpolyposis colon cancer
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Human Genome Research Institute (NHGRI)
- Principal Investigator
- Barbara B BieseckerNational Human Genome Research Institute (NHGRI)
- Enrollment
- 27 enrolled
- Eligibility
- 18-100 years · All sexes
- Timeline
- 2012 – 2016
Study locations (1)
- National Human Genome Research Institute (NHGRI), 9000 Rockville Pike, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01646112 on ClinicalTrials.govOther trials for Hereditary nonpolyposis colon cancer
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07163403First in Human Pilot Study to Assess the Safety and Efficacy of Dendritic Cells Loaded With Frameshift Derived Neopeptides for the Prevention of Cancer in of Lynch Syndrome CarriersFundacion Clinic per a la Recerca Biomédica
- RECRUITINGPHASE1, PHASE2NCT06898450A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.Nimbus Wadjet, Inc.
- RECRUITINGNANCT05963191CAD-EYE System for the Detection of Neoplastic Lesions in Patients With Lynch SyndromePERROD Guillaume
- RECRUITINGNCT06708429Lynch Syndrome X-Talk of Enteral Mucosa With Immune SystemSan Raffaele University
- ACTIVE NOT RECRUITINGPHASE2NCT05419011Testing a Combination of Vaccines for Cancer Prevention in Lynch SyndromeNational Cancer Institute (NCI)
- RECRUITINGNANCT07219537A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE CapsuleMassachusetts General Hospital
- ACTIVE NOT RECRUITINGPHASE1NCT05078866Cancer Preventive Vaccine Nous-209 for Lynch Syndrome PatientsNational Cancer Institute (NCI)
- ACTIVE NOT RECRUITINGPHASE3NCT02813824Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch SyndromeAssistance Publique - Hôpitaux de Paris